Among ALS patients with AIDs, 8 (30.8%) had a history of immunotherapy and showed slightly prolonged survival compared with those without immunotherapy, but the results did not reach statistical significance ( p = 0.355).
← all excerpts
Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
1
0.3550
0.3550